Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
10.1111/nph.12049 New Phytol
Phase 1B, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral NLRP3 inhibitor dapansutrile in subjects with NYHA II-III systolic heart failure
Maintains Bone Density & Bone Health
Quality enhancement in the Japanese sea bass (Lateolabrax japonicas) fillets stored at 4 C by chitosan coating incorporated with citric acid or licorice extract
Participants in the higher glutathione group lost 9.08% of their original body weight and approximately 24% of body fat, compared to 5.68% and 19.73%, respectively, for the lower glutathione group
